DEC 09, 2019 9:15 AM PST

Could the diabetic drug 'metformin' extend a healthy lifespan?

WRITTEN BY: Nouran Amin

The most commonly prescribed diabetic medication for the Type 2 condition is ‘Metformin’—a drug with a mysterious mechanism of action but ultimately controls blood sugar levels. Now, a collaborative team of researchers have aimed to investigate metformin using computational analysis. Their findings, published in Cell Reports, shows that metformin involves key biochemical actviation in many cellular physiology that support an extension of a healthy lifespan.

“These results provide us with new avenues to explore in order to understand how metformin works as a diabetes drug, along with its health-span-extending effects,” says Professor Reuben Shaw, co-corresponding author of the paper and the director of Salk’s NCI-designated Cancer Center. “These are pathways that neither we, nor anyone else, would have imagined.”

Computational analysis revealing targets of metformin. Caption and Image Credit: Salk Institute

Earlier studies on metformin revealed that the only biochemical mechanism activated by its action was the ‘AMPK pathway’ which stalls cell growth and alters metabolism when nutrients are low. However, these studies led scientists to believe that more pathways are activated by metformin beyond the AMPK.

Learn more:

“Being mentored by John Yates, one of the top mass spectrometry investigators in the world, and Reuben Shaw, an expert in the field of metabolism, enabled me to both develop and apply a novel technology to a critical biological question: What pathways are regulated by metformin in the liver?” says Ben Stein, first author and postdoctoral associate at Weill Cornell Medical College.

How scientists were able to tell what kind of pathways were specifically activated? For one, they developed a novel method to investigate proteins known as ‘kinases’ that transfer phosphate groups and are critical on/off switches in cells that can be rapidly flipped by the actions of metformin. These regulatory kinases are involved in aging which thus implicates metformin.

“The results broaden our understanding of how metformin induces a mild stress that triggers sensors to restore metabolic balance, explaining some of the benefits previously reported such as extended healthy aging in model organisms taking metformin. The big questions now are what targets of metformin can benefit the health of all individuals, not just type 2 diabetics,” says William R. Brody Chair.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 15, 2020
Cancer
JAN 15, 2020
Hope for patients with AML
Research published recently in the medical journal EMBO Molecular Medicine brings hope for leukemia patients with a report that a common and cheap drug may...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Treating Malaria: Molecular Understanding of Drug Interactions
Crystallization is a process central to drug development that despite centuries of facilitating a particular method, chemists are still learning how to gra...
FEB 20, 2020
Drug Discovery & Development
FEB 20, 2020
Antibiotics for Superbug Infections?
Antibiotics for superbug infections? A study published in the Proceedings of the National Academy of Sciences claims that a combination of compounds can ta...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
Healing Bone Fractures
Studies on rats revealed that two existing drugs can boost repair machinery by triggering the release of bone marrow stem cells. Findings were published in...
FEB 27, 2020
Drug Discovery & Development
FEB 27, 2020
New Drug Shows Promise in Treating Chronic Cough
Between 4% and 10% of adults around the world have an unexplainable chronic cough that has lasted for over 8 weeks. Although no treatments are currently av...
MAR 05, 2020
Drug Discovery & Development
MAR 05, 2020
Human Stem Cells Cure Type 1 Diabetes in Mice
In the US alone, around 187,000 children and adolescents have Type 1 diabetes, alongside 1.4 million people aged 20 and over. Managing their condition with...
Loading Comments...